Article

EOA accepting applications for technology grants

Essilor of America Inc. (EOA) is now accepting applications for the 2007 Essilor Optical Technology Grants. The grants will be awarded to schools and colleges that demonstrate a commitment to growing the optical industry through new advancements and technology.

Dallas-Essilor of America Inc. (EOA) is now accepting applications for the 2007 Essilor Optical Technology Grants. The grants will be awarded to schools and colleges that demonstrate a commitment to growing the optical industry through new advancements and technology.

Applicants must submit an essay of 1,000 words or less describing why the prospective institution needs and deserves the grant.

All applications will be judged on the school's commitment to the growth of premium optical technology, as well as how the funding will enable the school to elevate its standards and the visibility of ophthalmic dispensing for students and patients.

Applications are available by contacting Danne Ventura at dventura@essilor.com
. All applications must be signed by and accompanied by a letter from the dean or president of the school. Only one application per school may be submitted. Completed applications should be sent to the attention of Danne Ventura by e-mail or by conventional mail at Essilor Lenses, 13555 North Stemmons Freeway, Dallas, TX 75234.

Deadline for submitting an application electronically-on CD-ROM or by e-mail-is Nov. 1. Essilor will announce the recipients on Dec. 1.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.